Unlocking Mucosal Immunity: The Untapped Potential of Intradermal Vaccination
The worldwide impact of infectious diseases driven by mucosal pathogens remains high — highlighting the need for more effective prevention strategies.
Our latest white paper, Unlocking Mucosal Immunity: The Untapped Potential of Intradermal Vaccination, explores:
- The global burden of infectious diseases caused by mucosal pathogens
- The mucosal immune system — a complex and highly specialized immune network
- Intradermal vaccination as an alternative vaccine delivery method
- VAX-ID — a CE-marked intradermal drug delivery device enabling reliable skin delivery of medical products